33 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33035787 | Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma. | 2020 Dec | 1 |
2 | 33280607 | Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms. | 2020 Dec 6 | 1 |
3 | 30854066 | GSTP1 as a potential predictive factor for adverse events associated with platinum-based antitumor agent-induced peripheral neuropathy. | 2019 Mar | 1 |
4 | 30372807 | Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p. | 2018 Dec | 1 |
5 | 24765164 | Long-term administration and efficacy of oxaliplatin with no neurotoxicity in a patient with rectal cancer: Association between neurotoxicity and the GSTP1 polymorphism. | 2014 May | 2 |
6 | 24847383 | ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy. | 2014 | 1 |
7 | 23299794 | XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis. | 2013 Mar | 3 |
8 | 23604281 | Genetic polymorphisms of ERCC1‑118, XRCC1‑399 and GSTP1‑105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatin‑based adjuvant chemotherapy. | 2013 Jun | 1 |
9 | 23695028 | Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis. | 2013 Aug | 4 |
10 | 24137384 | Polymorphisms of GSTP1, ERCC2 and TS-3'UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients. | 2013 Sep | 1 |
11 | 21940361 | Predictive value of expression of ERCC 1 and GST-p for 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer. | 2012 Jan-Feb | 2 |
12 | 22994779 | GSTP1, ERCC1 and ERCC2 polymorphisms, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in colorectal cancer in Chinese population. | 2012 | 2 |
13 | 21468552 | Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review). | 2011 Mar-Apr | 1 |
14 | 21619788 | [Modification of GSTM1, GSTT1 and GSTP1 gene polymorphisms on urinary 1-hydroxypyrene excretions]. | 2011 Jan | 4 |
15 | 21787681 | The influence of metabolic gene polymorphisms on urinary 1-hydroxypyrene concentration in Thai bus drivers. | 2011 Jan | 2 |
16 | 19922504 | Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma. | 2010 Feb | 1 |
17 | 20308030 | Associations between glutathione S-transferase pi Ile105Val and glyoxylate aminotransferase Pro11Leu and Ile340Met polymorphisms and early-onset oxaliplatin-induced neuropathy. | 2010 Apr | 1 |
18 | 20514304 | Genetic polymorphism of GSTP1: prediction of clinical outcome to oxaliplatin/5-FU-based chemotherapy in advanced gastric cancer. | 2010 Jun | 3 |
19 | 20979931 | Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes. | 2010 Nov | 1 |
20 | 21029695 | [Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin/5-Fu-based chemotherapy]. | 2010 Jul | 2 |
21 | 19084393 | Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients. | 2009 Mar | 2 |
22 | 19247656 | Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. | 2009 Oct | 2 |
23 | 20047135 | Genetic polymorphisms of GSTP1 related to response to 5-FU-oxaliplatin-based chemotherapy and clinical outcome in advanced colorectal cancer patients. | 2009 Dec 12 | 3 |
24 | 18633248 | [Impact of single nucleotide polymorphisms in glutathione S transferase gene GSTP1 in the treatment with oxaliplatin based chemotherapy]. | 2008 Jul | 2 |
25 | 19098406 | [Single nucleotide polymorphism analysis in the GSTP1 and ABCC2 genes about neuropathy by the Oxaliplatin]. | 2008 Dec | 2 |
26 | 17322540 | Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer. | 2007 Mar | 2 |
27 | 17498780 | The influence of metabolic gene polymorphisms on urinary 1-hydroxypyrene concentrations in Chinese coke oven workers. | 2007 Aug 1 | 1 |
28 | 18085999 | Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome. | 2007 Dec | 2 |
29 | 16707601 | Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy. | 2006 May 15 | 4 |
30 | 15890268 | Predicting drug response and toxicity based on gene polymorphisms. | 2005 Jun | 1 |
31 | 15213713 | A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. | 2004 Jul 19 | 1 |
32 | 12072547 | Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. | 2002 Jun 19 | 1 |
33 | 11600727 | Urinary 1-hydroxypyrene in coke oven workers relative to exposure, alcohol consumption, and metabolic enzymes. | 2001 Nov | 1 |